Jonatan Freilich

Jonatan Freilich is currently the Evidence Generation Lead for International Markets at UCB, where they lead cross-functional execution of real-world evidence (RWE) projects in the APAC, LATAM, and Middle East regions. They possess a strong background in quantitative and qualitative methodologies, with research experience from prestigious institutions including KTH, MIT, and Karolinska. Jonatan previously held roles such as Senior Director of RWE and analytics at Parexel, where they contributed to innovative RWE solutions and project execution. They earned a PhD in Industrial Economics and Management from KTH Royal Institute of Technology, focusing on the managerial challenges of implementing biomarker technologies in the pharmaceutical industry.